Organon (OGN) news
Recent news
Sun Pharma: significant favourable development for co
Sun Pharmaceutical Industries Ltd. has recently reported several developments that indicate progress in its strategic initiatives and product portfolio expansion. The company announced approval to manufacture and market semaglutide in Brazil and South Africa, expanding its reach in key…
AInvest Wire · Aug 17, 2026Brazil regulator clears Organon's acquisition by Sun Pharma
Brazil’s regulatory authorities have cleared the proposed acquisition of Organon by Sun Pharmaceutical Industries Limited, a key step toward finalizing the US$11.75 billion all-cash transaction. The approval follows a comprehensive review of the deal’s compliance with local market competition and…
AInvest Wire · Aug 5, 2026Moody's Ratings says successful acquisition of Organon by Sun Pharma could lead to a multiple-notch upgrade of Organon's ratings
Moody's Ratings has indicated that the successful acquisition of Organon by Sun Pharmaceutical Industries Limited could result in a multiple-notch upgrade of Organon’s credit ratings, reflecting the strategic and financial benefits of the transaction. The deal, valued at an enterprise value of…
AInvest Wire · Jul 27, 2026Sun Pharma notes Organon shareholder approval for acquisition
Sun Pharmaceutical Industries Limited (Sun Pharma) has announced that it has entered into a definitive agreement to acquire Organon & Co. (Organon) in an all-cash transaction valued at $11.75 billion, with Organon shareholders to receive $14.00 per share. The deal, which has been approved by the…
AInvest Wire · Jul 24, 2026Organon completes agreement to license MiuDella
Organon Inc. has finalized an agreement to license MiuDella, a product developed by a third-party entity, as part of its ongoing strategy to expand its portfolio in women’s health and biospecialties. The licensing deal was announced earlier this year and has now been completed, marking a…
AInvest Wire · Jun 22, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.